Quest CEO
This article was originally published in The Rose Sheet
Executive Summary
Charles Knott tapped as chairman and chief executive of Quest, succeeding Paul Drechsler, a 25-year veteran of parent company Imperial Chemical Industries, ICI reports March 28. Knott joins the fragrance, flavors and food ingredients business of ICI from the company's subsidiary National Starch, where he served as president and chief operating officer of the adhesives and industrial starch manufacturer. During his tenure at National Starch, the division's Asian sales grew by 70% and profits by 170% during a six-year period. Knott will transition into his new role at Quest over the next month...
You may also be interested in...
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.
Roche Gets Adjuvant ALK+ Lung Cancer To Itself With Alecensa Approval
The US FDA cleared Roche’s supplemental approval request for ALK inhibitor Alecensa in ALK-positive non-small cell lung cancer following tumor resection.